Maven Securities’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.75M Sell
10,100
-5,900
-37% -$1.21M 0.03% 278
2025
Q4
$4.1M Sell
16,000
-15,300
-49% -$4.01M 0.09% 205
2025
Q3
$8.14M Buy
31,300
+11,800
+61% +$3.1M 0.2% 106
2025
Q2
$4.77M Buy
19,500
+10,900
+127% +$2.72M 0.11% 180
2025
Q1
$2.28M Buy
+8,600
New +$2.33M 0.07% 256
2024
Q1
Sell
-2,000
Closed -$916K 646
2023
Q4
$916K Sell
2,000
-3,800
-66% -$1.87M 0.02% 501
2023
Q3
$2.82M Buy
5,800
+4,400
+314% +$2.07M 0.03% 304
2023
Q2
$626K Buy
1,400
+900
+180% +$453K 0.01% 566
2023
Q1
$243K Buy
500
+100
+25% +$49.4K 0.01% 844
2022
Q4
$205K Sell
400
-1,100
-73% -$578K ﹤0.01% 779
2022
Q3
$728K Buy
+1,500
New +$730K 0.01% 653
2022
Q2
Sell
-800
Closed -$348K 986
2022
Q1
$348K Sell
800
-1,700
-68% -$711K 0.01% 656
2021
Q4
$1.16M Buy
2,500
+1,600
+178% +$708K 0.03% 303
2021
Q3
$350K Sell
900
-2,500
-74% -$1.06M 0.01% 787
2021
Q2
$1.5M Buy
3,400
+2,300
+209% +$1M 0.06% 305
2021
Q1
$461K Buy
+1,100
New +$439K 0.02% 699

Other funds holding HUM

Maven Securities's HUM Position: Q3 2025 in Review

Maven Securities sold out of Humana (HUM) in Q3 2025, closing a stake of 2,926 shares — an estimated $769K sold.

Maven Securities first reported a position in HUM in Q4 2020 and held it in 7 quarters. The position peaked at $715K in Q2 2025. 890 funds tracked by Wall St. Rank hold HUM as of Q3 2025.

  • Maven Securities reported no remaining Humana position as of Q3 2025 after selling out during the quarter.
  • Maven Securities sold 2,926 Humana shares in Q3 2025, an estimated $769K.
  • Maven Securities first reported a position in Humana in Q4 2020 and held it in 7 quarters.
  • Maven Securities's Humana position peaked at $715K in Q2 2025.
  • 890 funds tracked by Wall St. Rank held Humana as of Q3 2025.

Based on Maven Securities's 13F filing for Q3 2025, filed 20 Nov 2025.